On the toxicity of methylene blue

Abstract

Methylene blue was discovered by the chemist Careau at the end of the 19th century. R. Koch, in 1882, first used it in microscopic technique, working with the tuberculosis pathogen he had discovered. Later, in 1890, Ehrlich noticed the affinity of methylene blue for nerve tissue and its analgesic effect. A year later it was suggested by Gutmann, and then by Giems for treatment of malaria. Since that time, blue has been used for the treatment of a wide variety of diseases and, as can be seen from the literature, with some success, for example, in diseases of the urinary tract of a gonorrheic nature, in dysentery, recurrent typhus, in tuberculosis of the throat, in neoplasms, nephritis of an infectious nature, etc.

Keywords

Kazan Medical archive

References

[1] Иванов. Лечение малярии метиленовой синькой. Дисс. М. 1901.

[2] Laverаn. Палюдизм Рус. пер. В.-Мед. Ж. 1901.

[3] Нефедьев. Лечение метиленовой синькой возвратного тифа. Об. Рус. Вр. в СПБ., 1896, 97 г.

[4] Тенфильев. К вопр. о метиленовой синьке при заразных болезнях. Дисс. СПБ. 1907.

[5] Муффель. Лечение малярии. 1921.

[6] Кравков Фармакология, II ч. 1913.

[7] Кушев. Лекции по малярии. Саратов. 1924.

[8] Кушев. Лечение малярии подкожными впрыскиваниями хинина с метиленовой синькой. Вр. Дело, 1921, № 16—21,

[9] Ляховецкий. Троп. Журн., 1924, № 2.

RIGHTS & PERMISSIONS

Puchek A.I.